5743663

9780192616272

Psychopharmacology: Recent Advances and Future Prospects

Psychopharmacology: Recent Advances and Future Prospects

Out of Stock

The item you're looking for is currently unavailable.

Ask the provider about this item.

Most renters respond to questions in 48 hours or less.
The response will be emailed to you.
Cancel
  • ISBN-13: 9780192616272
  • ISBN: 0192616277
  • Publication Date: 1986
  • Publisher: Oxford University Press, Incorporated

AUTHOR

Iversen, Susan D.

SUMMARY

This volume presents results from the tenth anniversary meeting of the British Association for Psychopharmacology. It differs from previous BAP monographs in being a general review of the entire discipline, describing extensive recent progress, and identifying areas where work remains to be done. The papers focus on five major areas: depression and antidepressants, anxiolytics, cognitive disorders (particularly Alzheimer's disease), schizophrenia, and various forms of drug addiction. Topics addressed include the proliferation of new pharmaceutical agents, undesirable side effects, the potential hazards of current emphasis on the dopamine overactivity hypothesis, and the impact of CNS drugs. This will be an important resource for clinicians in neurology, psychiatry, and pharmacology; pharmacologists; and students and researchers in psychology, especially neuropsychology and behavioral pharmacology.Iversen, Susan D. is the author of 'Psychopharmacology: Recent Advances and Future Prospects', published 1986 under ISBN 9780192616272 and ISBN 0192616277.

[read more]

Questions about purchases?

You can find lots of answers to common customer questions in our FAQs

View a detailed breakdown of our shipping prices

Learn about our return policy

Still need help? Feel free to contact us

View college textbooks by subject
and top textbooks for college

The ValoreBooks Guarantee

The ValoreBooks Guarantee

With our dedicated customer support team, you can rest easy knowing that we're doing everything we can to save you time, money, and stress.